香港股市 將在 34 分鐘 開市

Roche Holding AG (RHHVF)

Other OTC - Other OTC 延遲價格。貨幣為 USD。
加入追蹤清單
331.00+17.86 (+5.70%)
收市價: 02:58PM EDT

Roche Holding AG

Konzern Hauptsitz
Grenzacherstrasse 124
Basel 4070
Switzerland
41 61 688 11 11
https://www.roche.com

版塊Healthcare
行業Drug Manufacturers—General
全職員工100,920

高階主管

名稱標題支付行使價出生年份
Dr. Severin Schwan Ph.D.CEO & Exec. Director7.66M1967
Dr. Alan HippeChief Financial & Information Officer4.39M1967
Ms. Cristina A. WilburChief People Officer3.14M1967
Dr. Johannes Carolus Clevers M.D., Ph.D.Head of Roche Pharma Research & Early Devel.356.52k1957
Dr. Thomas SchineckerChief Exec. Officer of Roche Diagnostics3.01M1975
Mr. William N. AndersonChief Exec. Officer of Roche Pharmaceuticals6.61M1966
Dr. Bruno EschliHead of Investor Relations
Ms. Claudia BockstiegelGen. Counsel1964
Ms. Pascale SchmidtChief Compliance Officer1973
Ms. Barbara SchadlerHead of Group Communications1962
截止 2021年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

公司管治

截至 2022年9月1日 止,Roche Holding AG 的 ISS 管治質素評分為 9。 Pillar 分數正在審核中:10;董事會:6;股東權利:1;現金賠償:8。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。